{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:16Z","timestamp":1790494096166,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI16C2130"],"award-info":[{"award-number":["HI16C2130"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brain Korea (BK) 21 PLUS program"},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T17:00:29Z","timestamp":1550509229000},"page":"1554-1564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Induction of Th2-related immune responses and production of systemic IgA in mice intranasally immunized with Brucella abortus malate dehydrogenase loaded chitosan nanoparticles"],"prefix":"10.1016","volume":"37","author":[{"given":"Sang Hee","family":"Soh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soojin","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bin","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Tae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Su","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Sang","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.005_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.micpath.2017.06.019","article-title":"Th2-related immune responses by the Brucella abortus cellular antigens, malate dehydrogenase, elongation factor, and arginase","volume":"110","author":"Im","year":"2017","journal-title":"Microb Pathog"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.005_b0010","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2006.12.004","article-title":"Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization","volume":"25","author":"Yang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.005_b0015","series-title":"Brucellosis in terrestrial wildlife","author":"Godfroid","year":"2013"},{"issue":"22","key":"10.1016\/j.vaccine.2019.02.005_b0020","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.005_b0025","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2006.09.051","article-title":"Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev. 1 deletion mutants in sheep","volume":"25","author":"Jacques","year":"2007","journal-title":"Vaccine"},{"issue":"12\u201313","key":"10.1016\/j.vaccine.2019.02.005_b0030","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.micinf.2008.08.003","article-title":"Acute infection by conjunctival route with Brucella melitensis induces IgG+ cells and IFN-\u03b3 producing cells in peripheral and mucosal lymph nodes in sheep","volume":"10","author":"Suraud","year":"2008","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet Res"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.005_b0040","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.005_b0050","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/IAI.71.9.4857-4861.2003","article-title":"A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB\/c mice","volume":"71","author":"Onate","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.005_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsle\/fnv003","article-title":"Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB\/c mice","volume":"362","author":"Hop","year":"2015","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2019.02.005_b0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.micpath.2015.05.004","article-title":"Evaluation of the combined use of the recombinant Brucella abortus Omp10, Omp19 and Omp28 proteins for the clinical diagnosis of bovine brucellosis","volume":"83","author":"Simborio","year":"2015","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2019.02.005_b0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.micpath.2018.06.007","article-title":"Cytokines production and toll-like receptors expression in human leukemic monocyte cells, THP-1, stimulated with Brucella abortus cellular antigens","volume":"122","author":"Im","year":"2018","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.005_b0070","doi-asserted-by":"crossref","first-page":"e17425","DOI":"10.1371\/journal.pone.0017425","article-title":"Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection","volume":"6","author":"Lowry","year":"2011","journal-title":"PLoS ONE"},{"issue":"19","key":"10.1016\/j.vaccine.2019.02.005_b0075","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.vaccine.2006.01.011","article-title":"Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally","volume":"24","author":"Jaganathan","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0080","doi-asserted-by":"crossref","first-page":"e16203","DOI":"10.1371\/journal.pone.0016203","article-title":"An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice","volume":"6","author":"Pasquevich","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.005_b0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"42","key":"10.1016\/j.vaccine.2019.02.005_b0090","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1016\/j.vaccine.2016.08.072","article-title":"Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine","volume":"34","author":"Tabynov","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.005_b0095","doi-asserted-by":"crossref","first-page":"e82765","DOI":"10.1371\/journal.pone.0082765","article-title":"Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis","volume":"8","author":"Yin","year":"2013","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.02.005_b0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Marttin","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2019.02.005_b0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.005_b0110","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ejpb.2004.05.006","article-title":"In vitro study of the immune stimulating activity of an athrophic rhinitis vaccine associated to chitosan microspheres","volume":"58","author":"Jiang","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2019.02.005_b0115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ijbiomac.2016.02.015","article-title":"Chitosan nanoparticles reduce LPS-induced inflammatory reaction via inhibition of NF-\u03baB pathway in Caco-2 cells","volume":"86","author":"Tu","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.005_b0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2006.01.010","article-title":"In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT","volume":"63","author":"Kang","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cimid.2006.09.006","article-title":"Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine","volume":"30","author":"Yang","year":"2007","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.005_b0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2016.05.032","article-title":"Nasal immunization with mannan-decorated mucoadhesive HPMCP microspheres containing ApxIIA toxin induces protective immunity against challenge infection with Actinobacillus pleuropneumoiae in mice","volume":"233","author":"Li","year":"2016","journal-title":"J Control Release"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.02.005_b0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-409X(97)00069-0","article-title":"Microspheres as nasal drug delivery systems","volume":"29","author":"Pereswetoff-Morath","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.02.005_b0140","first-page":"1","article-title":"Chitosan microspheres as a potential carrier for drugs","volume":"274","author":"Sinha","year":"2004","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejpb.2005.08.006","article-title":"Chitosan microparticles containing plasmid DNA as potential oral gene delivery system","volume":"62","author":"Guliyeva","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.005_b0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/(SICI)1097-4628(19990131)71:5<747::AID-APP9>3.0.CO;2-6","article-title":"Chitosan microspheres: modification of polymeric chem-physical properties of spray-dried microspheres to control the release of antibiotic drug","volume":"71","author":"Mi","year":"1999","journal-title":"J Appl Polym Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.20506\/rst.32.1.2187","article-title":"Epidemiology of brucellosis in domestic animals caused by Brucella melitensis, Brucella suis and Brucella abortus","volume":"32","author":"Aparicio","year":"2013","journal-title":"Rev sci tech Off int Epiz"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.005_b0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3325\/cmj.2010.51.289","article-title":"Brucellosis\u2013regionally emerging zoonotic disease?","volume":"51","author":"Gwida","year":"2010","journal-title":"Croatian Med J"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.005_b0165","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.vaccine.2015.10.067","article-title":"Partial protective immunity against toxoplasmosis in mice elicited by recombinant Toxoplasma gondii malate dehydrogenase","volume":"34","author":"Liu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.005_b0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2018.01.022","article-title":"A novel Th1-type T-cell immunity-biasing effect of malate dehydrogenase derived from Mycobacterium avium subspecies paratuberculosis via the activation of dendritic cells","volume":"104","author":"Kim","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2019.02.005_b0175","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.2147\/IJN.S116063","article-title":"A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides","volume":"12","author":"Barbari","year":"2017","journal-title":"Int J Nanomed"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2019.02.005_b0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0168-3659(90)90133-E","article-title":"Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches","volume":"11","author":"Eldridge","year":"1990","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-7-10","article-title":"Mucociliary and long-term particle clearance in airways of patients with immotile cilia","volume":"7","author":"M\u00f6ller","year":"2006","journal-title":"Respir Res"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.005_b0190","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0142-9612(00)00231-3","article-title":"Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches","volume":"22","author":"van der Lubben","year":"2001","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.005_b0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/pat.861","article-title":"Immune stimulating activity of an atrophic rhinitis vaccine associated to pegylated chitosan microspheres in vitro","volume":"18","author":"Jiang","year":"2007","journal-title":"Polym Adv Technol"},{"issue":"23","key":"10.1016\/j.vaccine.2019.02.005_b0200","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.vaccine.2007.03.038","article-title":"Pluronic\u00ae F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin","volume":"25","author":"Kang","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.005_b0205","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbrc.2007.05.042","article-title":"Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells","volume":"358","author":"Yoon","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4 T cell responses","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.005_b0215","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.autrev.2012.10.011","article-title":"Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives","volume":"12","author":"Mkaddem","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.005_b0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(02)00341-2","article-title":"Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo","volume":"17","author":"Phalipon","year":"2002","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.005_b0225","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri2322","article-title":"The regulation of IgA class switching","volume":"8","author":"Cerutti","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.02.005_b0230","series-title":"Mucosal Immunology","first-page":"623","article-title":"The mucosal B cell system","author":"Brandtzaeg","year":"2015"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:42:37Z","timestamp":1565185357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19301884"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of Th2-related immune responses and production of systemic IgA in mice intranasally immunized with Brucella abortus malate dehydrogenase loaded chitosan nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}